WallStreetZenWallStreetZen

NASDAQ: GENE
Genetic Technologies Ltd Stock Ownership - Who owns Genetic Technologies?

Insider buying vs selling

Have Genetic Technologies Ltd insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when GENE insiders and whales buy or sell their stock.

GENE Shareholders

What type of owners hold Genetic Technologies Ltd stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Morgan Stanley0.01%17,289$40.11kInstitution
Rhumbline Advisers0.00%3,739$8.67kInstitution
Ubs Group Ag0.00%2,994$6.95kInstitution
Wells Fargo Company0.00%130$301.60Institution
Simplex Trading LLC0.00%18$41.76Institution
Concourse Financial Group Securities Inc0.00%0$0.00Institution

1 of 1

GENE vs Diagnostic & Research Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
GENE0.02%0.00%
NDRA1.19%8.73%Net Buying
ISPC4.31%71.05%Net Buying
APDN9.45%72.88%
XWEL1.65%98.35%Net Buying

Genetic Technologies Stock Ownership FAQ

Who owns Genetic Technologies?

Genetic Technologies (NASDAQ: GENE) is owned by 0.02% institutional shareholders, 0.00% Genetic Technologies insiders, and 99.98% retail investors. Morgan Stanley is the largest individual Genetic Technologies shareholder, owning 17,289.00 shares representing 0.01% of the company. Morgan Stanley's Genetic Technologies shares are currently valued at $40.97k.

If you're new to stock investing, here's how to buy Genetic Technologies stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.